Relationship Between Adherence to Remote Monitoring and Patient Characteristics: Observational Study in Women With Pregnancy-Induced Hypertension.
Thijs Vandenberk, Dorien Lanssens, Valerie Storms...
https://pubmed.ncbi.nlm.nih.gov/31464190/Actively Recruiting
Led by Hasselt University · Updated on 2024-04-09
2000
Participants Needed
8
Research Sites
N/A
Total Duration
Pregnancy involves many changes in the cardiovascular system, but in pre-eclampsia PE, these changes are abnormal. PE affects 5 to 8 percent of pregnant women worldwide and is marked by high blood pressure and protein in the urine after 20 weeks of pregnancy. If not treated, PE can cause serious problems for both mother and baby. This research focuses on better monitoring and early detection of PE in high-risk pregnant women. The study compares two groups a control group receiving no intervention, and a remote monitoring group using special devices. At 10 weeks of pregnancy, all participants receive measurements with NICCOMO, maternal venous Doppler echography, and Maltron bio-electronic impedance analysis. These tests repeat at 20 weeks, and at 30 weeks if results are abnormal. The remote monitoring group uses devices to check blood pressure twice daily, activity continuously, and weight once daily. Participants will be monitored throughout their pregnancy with repeated tests and device tracking. Researchers will check blood pressure, heart and vein function, body measurements, activity levels, and weight at specific times. They will also collect birth-related information like birth weight, gestational age, delivery method, and timing. The study includes 2000 pregnant women and aims to improve follow-up and care for those at risk of PE.
CONDITIONS
LimPrOn: Limburg Pre-eclampsia Investigation
D
Dorien Lanssens, drs.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hasselt University
Lead Sponsor
Ziekenhuis Oost-Limburg
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From 10 weeks of pregnancy to delivery
Participants receive device-based monitoring including blood pressure, activity, and weight measurements starting from 10 weeks of pregnancy.
Measurements taken at 10, 20, and 30 weeks of pregnancy; blood pressure monitored twice daily; activity and weight tracked daily
Duration - Up to six weeks after delivery
Participants are observed for birth outcomes including birth weight, gestational age, mode of delivery, and timing of delivery.
1 to 2 visits after delivery
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Thijs Vandenberk, Dorien Lanssens, Valerie Storms...
https://pubmed.ncbi.nlm.nih.gov/31464190/Danielle C Ashworth, Sophie P Maule, Fiona Stewart...
https://pubmed.ncbi.nlm.nih.gov/32748394/Hasselt University
Lead Sponsor
Ziekenhuis Oost-Limburg
Collaborating Sponsor